SAMD4B and neoplasm: Fewer CD29+CD8+ T cells were found in high-SAMD4B-expression patients, who had a better prognosis, thus indicating that SAMD4B improved the immune microenvironment and weakened the immune escape of tumour cells from naive CD29+CD8+ T cells (Supplementary Fig. 13).